KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

ClearPoint Neuro (CLPT) Change in Cash (2018 - 2025)

ClearPoint Neuro (CLPT) has disclosed Change in Cash for 13 consecutive years, with $8.6 million as the latest value for Q4 2025.

  • Quarterly Change in Cash rose 683.53% to $8.6 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $26.9 million through Dec 2025, up 985.01% year-over-year, with the annual reading at $26.9 million for FY2025, 985.01% up from the prior year.
  • Change in Cash hit $8.6 million in Q4 2025 for ClearPoint Neuro, up from -$3.3 million in the prior quarter.
  • In the past five years, Change in Cash ranged from a high of $44.8 million in Q1 2021 to a low of -$26.1 million in Q2 2022.
  • Historically, Change in Cash has averaged $1.3 million across 5 years, with a median of -$2.9 million in 2024.
  • Biggest five-year swings in Change in Cash: tumbled 683.86% in 2022 and later surged 1269.62% in 2025.
  • Year by year, Change in Cash stood at -$3.5 million in 2021, then surged by 351.36% to $8.9 million in 2022, then crashed by 113.5% to -$1.2 million in 2023, then decreased by 22.21% to -$1.5 million in 2024, then skyrocketed by 683.53% to $8.6 million in 2025.
  • Business Quant data shows Change in Cash for CLPT at $8.6 million in Q4 2025, -$3.3 million in Q3 2025, and $29.3 million in Q2 2025.